21249 Results

People

  1. Brennan
    Brennan
  2. Jarnagin
    Jarnagin
  3. Abu-Rustum
    Abu-Rustum
  4. Rusch
    Rusch
  5. D'Angelica
    D'Angelica
  6. Fong
    Fong
  7. Morrow
    Morrow
  8. Shah
    Shah
  9. Chi
    Chi
  10. Shaha
    Shaha

Groups

  1. Surgery (21249)
  2. Survivorship Research (5131)
  3. Department of Medicine (4874)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4019)
  6. Epidemiology and Biostatistics (3680)
  7. Department of Pathology and Laboratory Medicine (3639)
  8. Center for Pancreatic Cancer Research (3115)
  9. Population Sciences Research Program (2966)
  10. GSK Faculty (2773)
  1. "Surgery"
Formats
  1. Journal Article (13275)
  2. Meeting Abstract (4871)
  3. Book Section (1145)
  4. Review (581)
  5. Editorial (559)
  6. Conference Paper (249)
  7. Correspondence (151)
  8. Miscellaneous (141)
  9. Guidelines (126)
  10. Book Whole (91)
  11. Research Letter (60)
Groups
  1. Surgery (21249)
  2. Survivorship Research (5131)
  3. Department of Medicine (4874)
  4. Urology (4507)
  5. Solid Tumor Oncology Division (4019)
  6. Epidemiology and Biostatistics (3680)

More Groups

People
  1. Murray Brennan (1059)
  2. William Jarnagin (903)
  3. Nadeem Abu-Rustum (888)
  4. Valerie Rusch (864)
  5. Michael D'Angelica (777)
  6. Yuman Fong (775)

More People

Years
  1. 2025 (375)
  2. 2024 (984)
  3. 2023 (930)
  4. 2022 (1036)
  5. 2021 (954)
  6. 2020 (920)

More Years

Publications
  1. Journal of Clinical Oncology (1551)
  2. Annals of Surgical Oncology (1512)
  3. Gynecologic Oncology (874)
  4. Journal of Urology (548)
  5. International Journal of Radiation Oncology, Biology, Physics (458)
  6. Cancer (424)

More Publications

Publishers
  1. Elsevier Inc. (3546)
  2. Springer (2678)
  3. Elsevier Science, Inc. (2049)
  4. Lippincott Williams & Wilkins (1663)
  5. American Society of Clinical Oncology (1644)
  6. Wiley Blackwell (1224)

More Publishers

Results (21249)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacokinetics of chemotherapy delivery for retinoblastoma
    Meeting Abstract

    Abramson, D. H.
    Investigative Ophthalmology & Visual Science (IOVS) (2016)

    Fulltext@MSK | Save
  • Ophthalmic artery chemosurgery as a local route for optic nerve delivery of chemotherapy
    Meeting Abstract

    Schaiquevich, P.; Taich, P.; Requejo, F.; Asprea, M.; Sgroi, M.; Gobin, P.; Abramson, D. H.; Chantada, G.
    Investigative Ophthalmology & Visual Science (IOVS) (2016)

    Fulltext@MSK | Save
  • Retinal reattachment and ERG recovery after ophthalmic artery chemosurgery for advanced retinoblastoma in eyes with minimal baseline retinal function
    Meeting Abstract

    Abdelhakim, A. H.; Francis, J. H.; Gobin, P.; Marr, B. P.; Abramson, D. H.; Brodie, S. E.
    Investigative Ophthalmology & Visual Science (IOVS) (2016)

    Fulltext@MSK | Save
  • Clinical characterization of vitreous seeds in retinoblastoma
    Meeting Abstract

    Francis, J. H.; Marr, B. P.; Abramson, D. H.
    Investigative Ophthalmology & Visual Science (IOVS) (2016)

    Fulltext@MSK | Save
  • Neutrophil to lymphocyte ratio in patients with primary uveal melanoma
    Meeting Abstract

    Iyer, S.; Barker, C. A.; Abramson, D. H.; Marr, B. P.; Francis, J. H.
    Investigative Ophthalmology & Visual Science (IOVS) (2016)

    Fulltext@MSK | Save
  • Intraocular pressure changes following intravitreal melphalan and topotecan for the treatment of retinoblastoma with vitreous seeding
    Meeting Abstract

    Karl, M.; Francis, J.; Iyer, S.; Marr, B. P.; Abramson, D. H.
    Investigative Ophthalmology & Visual Science (IOVS) (2016)

    Fulltext@MSK | Save
  • Simultaneous bilateral ophthalmic artery chemosurgery for bilateral retinoblastoma (tandem therapy)
    Meeting Abstract

    Mondesire-Crump, I.; Marr, B. P.; Francis, J. H.; Dunkel, I.; Gobin, P.; Fabius, A.; Brodie, S. E.; Abramson, D. H.
    Investigative Ophthalmology & Visual Science (IOVS) (2016)

    Fulltext@MSK | Save
  • An international survey of classification and treatment choices for group D retinoblastoma eyes
    Meeting Abstract

    Scelfo, C.; Francis, J. H.; Jenkins, T. L.; Marr, B. P.; Abramson, D. H.
    Investigative Ophthalmology & Visual Science (IOVS) (2016)

    Fulltext@MSK | Save
  • EMBARK: A phase 3, randomized, efficacy and safety study of enzalutamide plus leuprolide, enzalutamide monotherapy and placebo plus leuprolide in men with high-risk nonmetastatic prostate cancer progressing after definitive therapy
    Meeting Abstract

    Miller, K.; Mulders, P.; Freedland, S. J.; Scher, H.; Shore, N.; Park, E.; Krivoshik, A.; Phung, D.; Modelska, K.; Scardino, P.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save